Innovative Strategies to Improve Patient Access |
1.00 |
06/15/2025 - 12:00am to 03/01/2026 - 12:00am |
Integrative Medicine and the Cancer Patient |
0.50 |
08/04/2022 - 12:00am to 08/04/2025 - 12:00am |
Management of Advanced Gastroenteropancreatic Neuroendocrine Tumors |
0.75 |
06/15/2025 - 12:00am to 03/01/2026 - 12:00am |
Management of CNS Metastases in Patients with Breast Cancer |
0.75 |
03/15/2025 - 12:00am to 03/15/2026 - 12:00am |
Management of Immune Checkpoint Inhibitor-Related Toxicities |
1.00 |
06/15/2025 - 12:00am to 03/01/2026 - 12:00am |
Management of Multiple Myeloma: Smoldering, Newly Diagnosed, and Relapsed/Refractory Disease |
2.25 |
12/01/2024 - 12:00am to 12/01/2025 - 12:00am |
Management of TP53 Mutated Mantle Cell Lymphoma |
0.50 |
12/01/2024 - 12:00am to 12/01/2025 - 12:00am |
Managing Earlier Integration of Blinatumomab in the Treatment of Acute Lymphoblastic Leukemia |
0.75 |
12/01/2024 - 12:00am to 12/01/2025 - 12:00am |
Managing Multiple Medications – Polypharmacy |
0.50 |
08/04/2022 - 12:00am to 08/04/2025 - 12:00am |
Managing Pain in Cancer Survivors |
0.25 |
08/04/2022 - 12:00am to 08/04/2025 - 12:00am |
Managing Post-Treatment Complications for Multiple Myeloma and Acute Lymphocytic Leukemia |
1.00 |
12/01/2024 - 12:00am to 12/01/2025 - 12:00am |
Myelodysplastic Syndromes: Treatment Updates and Emerging Data |
0.50 |
12/01/2024 - 12:00am to 12/01/2025 - 12:00am |
Myeloma Masterclass: Applying the Latest Guidelines for Evidence-Based, Equitable Care |
1.50 |
05/31/2025 - 9:00pm to 07/02/2025 - 12:00am |
NCCN Guidelines® Insights - Colorectal Cancer Screening, Version 1.2024 |
1.00 |
09/10/2024 - 12:00am to 09/10/2025 - 12:00am |
NCCN Guidelines® Insights - Head and Neck Cancers, Version 2.2025 |
1.00 |
02/10/2025 - 12:00am to 02/10/2026 - 12:00am |